Assertion: vaccine's virus | /r/HasProperty | rsv
Facets:
Source sentences:
text: Respiratory syncytial virus (RSV): This pervasive respiratory virus has proven resistant to vaccination.
text: An early concern for application of a SARS-CoV vaccine was the experience with other coronavirus infections which induced enhanced disease and immunopathology in animals when challenged with infectious virus  , a concern reinforced by the report that animals given an alum adjuvanted SARS vaccine and subsequently challenged with SARS-CoV exhibited an immunopathologic lung reaction reminiscent of that described for respiratory syncytial virus (RSV) in infants and in animal models given RSV vaccine and challenged naturally (infants) or artificially (animals) with RSV  ,  .
text: Since the 1960s, tests of vaccine candidates for diseases such as dengue, respiratory syncytial virus (RSV), and severe acute respiratory syndrome (SARS) have shown a paradoxical phenomenon: Some animals or people who received the vaccine and were later exposed to the virus developed more severe disease than those who had not been vaccinated (1).
text: The nanoparticle-based technology also is being assessed as a platform for development of vaccines against MERS coronavirus, respiratory syncytial virus (RSV) and Epstein Barr virus.
text: Molecular genetics sets the scene for a bright future for vaccinology, including the development of new vaccine delivery systems (e.g. DNA vaccines, viral vectors, plant vaccines and topical formulations), new adjuvants, the development of more effective tuberculosis vaccines, and vaccines against cytomegalovirus (CMV), herpes simplex virus (HSV), respiratory syncytial virus (RSV), staphylococcal disease, streptococcal disease, pandemic influenza, shigella, HIV and schistosomiasis among others.
text: These non-flu viruses include rhinovirus (one cause of the “common cold”) and respiratory syncytial virus (RSV), which is the most common cause of severe respiratory illness in young children, and a major cause of severe respiratory illness in adults aged 65 years and older.
text: Some immunizations, such as those against respiratory syncytial virus (RSV), have been observed in the past to make disease worse when vaccinated individuals contract the virus.
text: Different routes to immune enhancement came to the foreground in the 1960s during clinical trials where young children were immunized with whole-inactivated virus vaccines against respiratory syncytial virus (RSV).
text: These promising premises allowed the development of a vaccine against respiratory syncytial virus (RSV).
text: An experimental vaccine against respiratory syncytial virus (RSV), one of the leading causes of infectious disease deaths in infants, has shown early promise in a Phase 1 human clinical trial.